Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3370)
All Articles published online
|
Oct 7, 2008 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Donadon V, Balbi M, Casarin P, Vario A, Alberti A. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin. World J Gastroenterol 2008; 14(37): 5695-5700 [PMID: 18837086 DOI: 10.3748/wjg.14.5695] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i37/5695.htm |
| Number | Citing Articles |
| 1 |
Mohsen Janghorbani, Mohsen Dehghani, Mohammad Salehi-Marzijarani. Systematic Review and Meta-analysis of Insulin Therapy and Risk of Cancer. Hormones and Cancer 2012; 3(4): 137 doi: 10.1007/s12672-012-0112-z
|
| 2 |
Maysa A. Mobasher, Mousa O. Germoush, Hala Galal El-Tantawi, Karim Samy El-Said. Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus Rats. Pathogens 2021; 10(1): 59 doi: 10.3390/pathogens10010059
|
| 3 |
Hui Zhang, Chun Gao, Long Fang, Hong-Chuan Zhao, Shu-Kun Yao. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scandinavian Journal of Gastroenterology 2013; 48(1): 78 doi: 10.3109/00365521.2012.719926
|
| 4 |
Rodolphe Anty, Maud Lemoine. Liver fibrogenesis and metabolic factors. Clinics and Research in Hepatology and Gastroenterology 2011; 35: S10 doi: 10.1016/S2210-7401(11)70003-1
|
| 5 |
Diego García-Compean, Joel Omar Jaquez-Quintana, Héctor Maldonado-Garza. Hepatogenous diabetes. Current views of an ancient problem. Annals of Hepatology 2009; 8(1): 13 doi: 10.1016/S1665-2681(19)31805-8
|
| 6 |
Dipendra Kumar Jha, Ankush Mittal, Satrudhan Pd. Gupta, Dipendra Raj Pandeya, Brijesh Sathian. Association of Type II Diabetes Mellitus with Hepatocellular Carcinoma Occurrence - a Case Control Study from Kathmandu Valley. Asian Pacific Journal of Cancer Prevention 2012; 13(10): 5097 doi: 10.7314/APJCP.2012.13.10.5097
|
| 7 |
Habibeh Mashayekhi‐Sardoo, Amir Hooshang Mohammadpour, Homa Nomani, Amirhossein Sahebkar. The effect of diabetes mellitus on pharmacokinetics, pharmacodynamics and adverse drug reactions of anticancer drugs. Journal of Cellular Physiology 2019; 234(11): 19339 doi: 10.1002/jcp.28644
|
| 8 |
Diego García-Compeán, Joel O. Jáquez-Quintana, José A. González-González, Fernando J. Lavalle-González, Jesús Z. Villarreal-Pérez, Hector J. Maldonado-Garza. La diabetes en la cirrosis hepática. Gastroenterología y Hepatología 2013; 36(7): 473 doi: 10.1016/j.gastrohep.2013.01.012
|
| 9 |
Wei-Min Wang, Yang Xu, Xin-Rong Yang, Yao-Hui Wang, Hai-Xiang Sun, Jia Fan. Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis. Hepatobiliary & Pancreatic Diseases International 2011; 10(4): 346 doi: 10.1016/S1499-3872(11)60059-3
|
| 10 |
Isabel Sánchez-Crisóstomo, Eduardo Fernández-Martínez, Raquel Cariño-Cortés, Gabriel Betanzos-Cabrera, Rosa A. Bobadilla-Lugo. Phytosterols and Triterpenoids for Prevention and Treatment of Metabolic-related Liver Diseases and Hepatocellular Carcinoma. Current Pharmaceutical Biotechnology 2019; 20(3): 197 doi: 10.2174/1389201020666190219122357
|
| 11 |
Ramón Arturo Kobashi-Margáin, Ylse Gutiérrez-Grobe, Guadalupe Ponciano-Rodríguez, Misael Uribe, Nahum Méndez-Sánchez. Prevalence of type 2 diabetes mellitus and chronic liver disease: A retrospective study of the association of two increasingly common diseases in Mexico. Annals of Hepatology 2010; 9(3): 282 doi: 10.1016/S1665-2681(19)31638-2
|
| 12 |
Valter Donadon, Massimiliano Balbi, Antonio Perciaccante, Pietro Casarin, Giorgio Zanette. Insulin Resistance and Hyperinsulinemia in Patients with Chronic Liver Disease and Hepatocellular Carcinoma. Clinical medicine. Endocrinology and diabetes 2009; 2: CMED.S3116 doi: 10.4137/CMED.S3116
|
| 13 |
Shu-Chun Chuang, Yuan-Chin Amy Lee, Guo-Jie Wu, Kurt Straif, Mia Hashibe. Alcohol consumption and liver cancer risk: a meta-analysis. Cancer Causes & Control 2015; 26(9): 1205 doi: 10.1007/s10552-015-0615-3
|
| 14 |
Ayumi Debata, Koichi Yoshida, Kenta Ujifuku, Haruna Yasui, Kensaku Kamada, Daisuke Niino, Takayuki Matsuo. Hyperglycemia is Associated with Poor Survival in Primary Central Nervous System Lymphoma Patients. Tumori Journal 2017; 103(3): 272 doi: 10.5301/tj.5000590
|
| 15 |
Abu Jubayer Hossain, Rokibul Islam, Jae-Gyu Kim, Oyungerel Dogsom, Kim Cuong Cap, Jae-Bong Park. Pyruvate Dehydrogenase A1 Phosphorylated by Insulin Associates with Pyruvate Kinase M2 and Induces LINC00273 through Histone Acetylation. Biomedicines 2022; 10(6): 1256 doi: 10.3390/biomedicines10061256
|
| 16 |
Takumi Kawaguchi, Dan Nakano, Takuji Torimura. Alcoholic/Non-Alcoholic Digestive Diseases. 2019; : 65 doi: 10.1007/978-981-13-1465-0_7
|
| 17 |
Takumi Kawaguchi, Eitaro Taniguchi, Yasuyo Morita, Miki Shirachi, Ikuo Tateishi, Eisuke Nagata, Michio Sata. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection. Liver International 2010; 30(3): 479 doi: 10.1111/j.1478-3231.2009.02191.x
|
| 18 |
Catherine Mezzacappa, Nadim Mahmud, Marina Serper, Binu V. John, Tamar H. Taddei, David E. Kaplan. HCC is associated with diabetes and longitudinal blood glucose control in a national cohort with cirrhosis. Hepatology Communications 2023; 7(12) doi: 10.1097/HC9.0000000000000344
|
| 19 |
Hui-Lin Xu, Hong Fang, Wang-Hong Xu, Guo-You Qin, Yu-Jie Yan, Bao-Dong Yao, Nai-Qing Zhao, Yi-Nan Liu, Fen Zhang, Wei-Xi Li, Na Wang, Jie Zhou, Jin-Ling Zhang, Li-Yun Zhao, Lun-Qiang Li, Yan-Ping Zhao. Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1887-4
|
| 20 |
Gregory C. Connolly, Saman Safadjou, Rui Chen, Afamefuna Nduaguba, Richard Dunne, Alok A. Khorana, Aram F. Hezel. Diabetes Mellitus Is Associated With the Presence of Metastatic Spread at Disease Presentation in Hepatocellular Carcinoma. Cancer Investigation 2012; 30(10): 698 doi: 10.3109/07357907.2012.732162
|
| 21 |
Gregory C Connolly, Saman Safadjou, Randeep Kashyap, Rui Chen, Mark S Orloff, Aram F Hezel. Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-9
|
| 22 |
Jung Hoon Cha, Si Hyun Bae, Hye Lim Kim, Na Ri Park, Eun Suk Choi, Eun Sun Jung, Jong Young Choi, Seung Kew Yoon, Sang Hoon Ahn. Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis. PLoS ONE 2013; 8(11): e77899 doi: 10.1371/journal.pone.0077899
|
| 23 |
Laura Mazilu, Dana Stanculeanu, Andreea Gheorghe, Adrian-Paul Suceveanu, Irinel Parepa, Felix Voinea, Doina Catrinoiu, Andra-Iulia Suceveanu. Metformin [Working Title]. 2019; doi: 10.5772/intechopen.88803
|
| 24 |
Grace Sun, Sangeeta R. Kashyap. Cancer Risk in Type 2 Diabetes Mellitus: Metabolic Links and Therapeutic Considerations. Journal of Nutrition and Metabolism 2011; 2011: 1 doi: 10.1155/2011/708183
|
| 25 |
Achal Ganiga Lingaraj, Shisheer Havangi, Anish Bandalore Satheesha, Arjun Naidu, Ketan Garg, Bhawna Garg. Metformin use and Occurrence of Hepatocellular Carcinoma in Patients with Type II Diabetes Mellitus: A Systematic Review. Journal of Radiation and Cancer Research 2023; 14(4): 176 doi: 10.4103/jrcr.jrcr_65_22
|
| 26 |
Valter Donadon, Massimiliano Balbi, Maria Dal Mas, Pietro Casarin, Giorgio Zanette. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver International 2010; 30(5): 750 doi: 10.1111/j.1478-3231.2010.02223.x
|
| 27 |
Muhammad Sufyan, Usman Ali Ashfaq, Sajjad Ahmad, Fatima Noor, Muhammad Hamzah Saleem, Muhammad Farhan Aslam, Hamed A. El-Serehy, Sidra Aslam. Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis. Saudi Journal of Biological Sciences 2021; 28(10): 5518 doi: 10.1016/j.sjbs.2021.07.068
|
| 28 |
Victor Cunha, Helma Pinchemel Cotrim, Raquel Rocha, Kellyane Carvalho, Liliane Lins-Kusterer. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review. Annals of Hepatology 2020; 19(3): 232 doi: 10.1016/j.aohep.2019.10.005
|
| 29 |
Massimiliano Balbi, Valter Donadon, Michela Ghersetti, Silvia Grazioli, Giovanni Della Valentina, Rita Gardenal, Maria Dal Mas, Pietro Casarin, Giorgio Zanette, Cesare Miranda, Paolo Cimarosti. Alcohol and HCV Chronic Infection Are Risk Cofactors of Type 2 Diabetes Mellitus for Hepatocellular Carcinoma in Italy. International Journal of Environmental Research and Public Health 2010; 7(4): 1366 doi: 10.3390/ijerph7041366
|
| 30 |
István Tornai. Role of environmental factors in the etiology of hepatocellular carcinoma. Orvosi Hetilap 2010; 151(28): 1132 doi: 10.1556/oh.2010.28913
|
| 31 |
|
| 32 |
Hongmei Qu, Xingwang Yang. Metformin Inhibits Angiogenesis Induced by Interaction of Hepatocellular Carcinoma with Hepatic Stellate Cells. Cell Biochemistry and Biophysics 2015; 71(2): 931 doi: 10.1007/s12013-014-0287-8
|
| 33 |
Ikuyo Imayama, Caitlin Mason, Catherine Duggan. Physical Activity, Dietary Calorie Restriction, and Cancer. 2011; : 99 doi: 10.1007/978-1-4419-7551-5_6
|
| 34 |
Francesca Valent. Diabetes mellitus and cancer of the digestive organs: An Italian population-based cohort study. Journal of Diabetes and its Complications 2015; 29(8): 1056 doi: 10.1016/j.jdiacomp.2015.07.017
|
| 35 |
Asami Hagiwara, Megumi Nishiyama, Sonoko Ishizaki. Branched‐chain amino acids prevent insulin‐induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2‐dependent mechanisms. Journal of Cellular Physiology 2012; 227(5): 2097 doi: 10.1002/jcp.22941
|
| 36 |
Gabriela Oprea-Călin, Petru Aurel Babeș, Dan Valentin Andronescu, Crăița-Isabela Andronescu. Connection Between Non-Alcoholic Fatty Liver Disease and Diabetes Mellitus. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2014; 21(2): 121 doi: 10.2478/rjdnmd-2014-0017
|
| 37 |
Siddharth Singh, Preet Paul Singh, Abha Goyal Singh, Mohammad Hassan Murad, William Sanchez. Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 2013; 108(6): 881 doi: 10.1038/ajg.2013.5
|
| 38 |
Adélaïde Pladys, Cécile Couchoud, Aurélie LeGuillou, Muriel Siebert, Cécile Vigneau, Sahar Bayat, Germaine Wong. Type 1 and Type 2 Diabetes and Cancer Mortality in the 2002-2009 Cohort of 39 811 French Dialyzed Patients. PLOS ONE 2015; 10(5): e0125089 doi: 10.1371/journal.pone.0125089
|
| 39 |
Yao-Yao Zhou, Gui-Qi Zhu, Tian Liu, Ji-Na Zheng, Zhang Cheng, Tian-Tian Zou, Martin Braddock, Shen-Wen Fu, Ming-Hua Zheng. Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma. Scientific Reports 2016; 6(1) doi: 10.1038/srep33743
|
| 40 |
Fahad A. Alhumaydhi. Integrated computational approaches to screen gene expression data to determine key genes and therapeutic targets for type-2 diabetes mellitus. Saudi Journal of Biological Sciences 2022; 29(5): 3276 doi: 10.1016/j.sjbs.2022.02.004
|
| 41 |
Elizabeth A. Atchison, Gloria Gridley, J. Daniel Carreon, Michael F. Leitzmann, Katherine A. McGlynn. Risk of cancer in a large cohort of U.S. veterans with diabetes. International Journal of Cancer 2011; 128(3): 635 doi: 10.1002/ijc.25362
|
| 42 |
Adélaïde Pladys, Gautier Defossez, Pierre Lemordant, Mathilde Lassalle, Pierre Ingrand, Christian Jacquelinet, Christine Riou, Guillaume Bouzillé, Pascal Van Hille, Cécile Vigneau, Marc Cuggia, Sahar Bayat. Cancer risk in dialyzed patients with and without diabetes. Cancer Epidemiology 2020; 65: 101689 doi: 10.1016/j.canep.2020.101689
|
| 43 |
Valter Donadon, Massimiliano Balbi, Michela Ghersetti, Silvia Grazioli, Antonio Perciaccante, Giovanni Della Valentina, Rita Gardenal, Maria Dal Mas, Pietro Casarin, Giorgio Zanette, Cesare Miranda. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World Journal of Gastroenterology 2009; 15(20): 2506-2511 doi: 10.3748/wjg.15.2506
|
| 44 |
Shan Liu, Max Costa. Handbook on the Toxicology of Metals. 2022; : 507 doi: 10.1016/B978-0-12-823292-7.00014-0
|
| 45 |
Hala E. Thomas, Sara C. Kozma. Signaling Pathways in Liver Diseases. 2010; : 261 doi: 10.1007/978-3-642-00150-5_17
|
| 46 |
Pian-Hong Zhang, Zhong-Wen Chen, Duo Lv, Yu-Yang Xu, Wei-Ling Gu, Xu-Hui Zhang, Yuan-Luo Le, Hong-hong Zhu, Yi-Min Zhu. Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in China. BMC Public Health 2012; 12(1) doi: 10.1186/1471-2458-12-567
|
| 47 |
Diego Garcia-Compean, Joel Omar Jaquez-Quintana, Jose Alberto Gonzalez-Gonzalez, Hector Maldonado-Garza. Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World Journal of Gastroenterology 2009; 15(3): 280-288 doi: 10.3748/wjg.15.280
|
| 48 |
Andreas E. Buchs, Barbara G. Silverman. Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study. Metabolism 2011; 60(10): 1379 doi: 10.1016/j.metabol.2011.05.002
|
| 49 |
Bindiya Thakkar, Konstantinos N. Aronis, Maria T. Vamvini, Kelsey Shields, Christos S. Mantzoros. Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies. Metabolism 2013; 62(7): 922 doi: 10.1016/j.metabol.2013.01.014
|
| 50 |
Shenglan Gao, Aimin Li, Feiye Liu, Fengsheng Chen, Mark Williams, Chengliang Zhang, Zakiya Kelley, Chin-Lee Wu, Rongcheng Luo, Hua Xiao. NCOA5 Haploinsufficiency Results in Glucose Intolerance and Subsequent Hepatocellular Carcinoma. Cancer Cell 2013; 24(6): 725 doi: 10.1016/j.ccr.2013.11.005
|
| 51 |
Javier Ampuero, Manuel Romero-Gomez. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin. World Journal of Hepatology 2015; 7(8): 1105-1111 doi: 10.4254/wjh.v7.i8.1105
|